John Power

Founder and CEO of Aerogen - Leadership Excellence in Medical Devices

Profile

A serial entrepreneur in a technology and innovation focused career spanning over 30 years, John has held executive-level positions in R&D, Operations, Sales, and General Management in both the SME and MNC environment. During this period he has been a founder or co-founder of several ÔBlue Ocean’ technology start-ups, the last three of these in the life-science sector.

John has led the company from a start-up in 1997 through a US merger, NASDAQ IPO, trade sale and return to a privately held company by MBO in 2008. Today, Aerogen is recognised as a pioneer and the global leader in ICU ventilator/hospital-based aerosol drug delivery. Its award-winning products are employed in over 75 countries throughout the world, helping to provide life critical interventions from the emergency department through to the NICU. Aerogen’s proprietary technology permits proteins, peptides, suspensions and solutions to be nebulized, paving the way for targeted drug delivery to the lung.

Under John’s Leadership Aerogen has achieved circa 30% CAGR since 2008 and in recognition of its export success, Aerogen was awarded the prestigious European Business Award Ruban d’Honneur in 2011 and again in 2016, when John was also named the European Entrepreneur of the Year. As a leader within the Irish life-science sector, Aerogen was named both The Irish Med-Tech Company of the Year and The Irish Exporter of the Year. The Company has received the highest award granted by the US respiratory community, the American Association of Respiratory Care, the Zenith Award, for Ôproviding products and services that enable respiratory care physicians and therapists to achieve clinical excellence’.

A Chartered Engineer, John is recognized as a technology innovator and is credited with over a dozen commercialized international patents in products ranging from robotics to life-support ventilation. He holds an MBA from Oxford Brookes University and as an Adjunct Professor at the National University of Ireland, Galway (NUIG), he guest lectures on his core business interests of Innovation Strategies and Technology Entrepreneurship.

He is a founder faculty member of the NUIG Bio-Innovate program (run in conjunction with Stanford University Bio-Design), an incubator unit that promotes entrepreneurial start-ups in medical technologies where he has actively mentored several early-stage companies. In 2016, in recognition of his contribution to the development of the Irish Medical Device sector, John was conferred with an Honorary Doctorate by the National University of Ireland, Galway.

FIRM PROFILE

Headquartered in Galway, Ireland, Aerogen is the world leader in acute care aerosol drug delivery. With over 25 years of experience, 300 international patents and associated with over 200 clinical papers and publications, Aerogen technology has been used to treat 16 million patients in 75 countries worldwide. Based on pioneering vibrating mesh technology, the Aerogen Solo vibrating mesh nebuliser has become the gold standard for respiratory patient care across the hospital from the emergency department to intensive care.

Aerogen’s dynamic R&D team is dedicated to the continuous improvement and development of aerosol drug delivery technology. Innovation and creativity are at the core of every product development programme, while Aerogen’s structured five-stage gate development process ensures that projects are executed in a methodical and cost-effective manner.

The company continues to leverage its expertise, research, technologies and partnerships to make the greatest possible difference to patient outcomes.

Award-winning technology with over 300 international active and pending patents made us a world leader in acute care aerosol drug delivery. Our technology is a breakthrough in aerosol drug delivery and is at the heart of all our products.